The proper functioning of Topoisomerase II is essential for maintaining genomic stability.When Topoisomerase II fails to properly resolve DNA tangles during mitosis, chromosomal segregation errors can occur.These errors lead to aneuploidy, or abnormal chromosome numbers, which can potentially trigger cancer development.Defects in Topoisomerase II activity have been linked to various genomic instability syndromes and cancers.Certain genetic rearrangements found in leukemias involve the Topoisomerase II gene, highlighting its importance in preventing oncogenic transformations.Beyond cancer, Topoisomerase II is also being studied for its potential role in neurodegenerative diseases and aging, as DNA damage accumulation is a hallmark of these conditions.Understanding Topoisomerase II function has led to the development of important chemotherapeutic agents.These include etoposide, which prevents the religation of DNA strands by stabilizing the Topoisomerase II-DNA complex.And doxorubicin, which intercalates into DNA and inhibits Topoisomerase II, leading to DNA damage in cancer cells.These agents remain cornerstones of cancer treatment despite their potential side effects, which can include secondary malignancies and cardiotoxicity.In summary, Topoisomerase II plays a critical role in maintaining genomic stability, with implications for cancer, leukemia, and neurodegenerative diseases. It also serves as an important target for cancer therapeutics.
Explore
Discover the full suite of AI-powered study tools designed to help you learn smarter.